We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-6.05%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$465M
AUM Growth
-$5.1M
Cap. Flow
+$31.7M
Cap. Flow %
6.82%
Top 10 Hldgs %
95.2%
Holding
19
New
1
Increased
7
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$36.7M
2
CI icon
Cigna
CI
+$4.65M
3
DERM
Dermira, Inc.
DERM
+$4.23M
4
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
+$3.69M
5
CFRX
ContraFect Corporation
CFRX
+$360K

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$7.09M
2
BIOL
Biolase, Inc.
BIOL
+$1.92M
3
AMRN
Amarin Corp
AMRN
+$1.79M

Sector Composition

Rank Sector Weight
1 Healthcare 95.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$106M 22.78%
1,785,264
-118,294
-6% -$7.09M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$99.7M 21.44%
435,636
+680
+0.2% +$133K
AMRN
3
Amarin Corp
AMRN
$293M
$99.5M 21.39%
256,449
-4,880
-2% -$1.79M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$73.3M 15.76%
1,672,950
+651,558
+64% +$36.7M
DERM
5
DELISTED
Dermira, Inc.
DERM
$16.8M 3.62%
1,760,072
+392,636
+29% +$4.23M
MOTS
6
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$11.4M 2.46%
12,556
+3,306
+36% +$3.69M
SLNO
7
DELISTED
Soleno Therapeutics
SLNO
$10.7M 2.3%
254,237
– –
OPK icon
8
Opko Health
OPK
$1.25B
$8.99M 1.93%
3,686,194
– –
VRML
9
DELISTED
Vermillion, Inc.
VRML
$8.74M 1.88%
9,825,289
– –
BIOL
10
DELISTED
Biolase, Inc.
BIOL
$7.61M 1.64%
2,069
-400
-16% -$1.92M
PACB icon
11
Pacific Biosciences
PACB
$432M
$6.72M 1.45%
1,110,666
– –
CI icon
12
Cigna
CI
$79.6B
$4.67M 1.01%
+29,653
New +$4.65M
AGEN
13
Agenus
AGEN
$275M
$4.23M 0.91%
71,784
+2,547
+4% +$139K
CFRX
14
DELISTED
ContraFect Corporation
CFRX
$3.24M 0.7%
7,946
+920
+13% +$360K
BIIB icon
15
Biogen
BIIB
$30.4B
$1.49M 0.32%
6,368
– –
AXDX
16
CALL
DELISTED
Accelerate Diagnostics
AXDX
$808K 0.17%
18,000
-2,640
-13% -$516K
BHVN
17
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$692K 0.15%
458,800
-280,200
-38% -$15.8M
AMRN
18
CALL
Amarin Corp
AMRN
$293M
$478K 0.1%
32,535
+24,265
+293% +$8.89M
PACB icon
19
CALL
Pacific Biosciences
PACB
$432M
– –
-500,000
Closed -$13K

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oracle Investment Management held 19 positions worth $465M, down 1.1% from $470M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management deployed $31.7M of net new capital in Q2 2019, opening 1 new position and adding to 7 existing holdings. Its largest new stake was Cigna: 29,653 shares worth $4.67M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

On the sell side, the largest reduction was QuidelOrtho, an estimated $7.09M trimmed.

  • Oracle Investment Management's largest Q2 2019 buy was Cigna: 29,653 shares worth $4.67M.
  • Oracle Investment Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $36.7M increase.
  • Oracle Investment Management's biggest Q2 2019 reduction was QuidelOrtho, cutting an estimated $7.09M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $465M portfolio in Q2 2019.
  • Oracle Investment Management opened 1 new position and closed 1 in Q2 2019.
  • Oracle Investment Management's portfolio value fell 1.1% quarter-over-quarter to $465M.

Based on Oracle Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.